Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

From the PhD to President & CEO

Dream of independence and your own company? Human Workflows and SciPhD co-founder Randy Ribaudo discusses the rewards and challenges of entrepreneurship, and how scientists can apply their problem-solving skills—and improve their communication skills—to successfully start and run a business.

Published March 15, 2013

Randall Ribaudo, PhD
President & CEO, Human Workflows

Human Workflows and SciPhD co-founder Randall Ribaudo has over twenty years of experience in the Scientific Research and biotechnology field and has successfully made the transition from academia to industry. Ribaudo co-founded Human Workflows after more than five years at Celera Genomics. Prior to Celera, Ribaudo worked at the biotechnology and bioinformatics company Molecular Applications Group, where he was responsible for presenting the revolutionary capabilities of MAG's products to representatives in the pharmaceutical, biotechnology and academic communities. Ribaudo also has extensive experience in the academic biological life sciences arena. After receiving a PhD in Immunology at the University of Connecticut, Ribaudo joined the Laboratory of Immunology, NIAID at the National Institutes of Health. He later accepted a position in the National Cancer Institute in the Laboratory of Immune Cell Biology as a Principal Investigator. There, he developed his own research program studying the immune response to viruses and tumors, leading a team of postdoctoral fellows, technicians, and University and High School students. His work at the National Cancer Institute led to the development of a novel technology to develop vaccines against tumors and viruses. Ribaudo holds patents for this technology which are now being further developed by private companies.

From the PhD to President & CEO

Randall Ribaudo (Human Workflows)